I had sbrt for 1 bone met, and ihc from it was Er50Pr0, Her2 negative. Initial ihc was Er90Pr30 adter surgery. Im...
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Question asked:
I had sbrt for 1 bone met, and ihc from it was Er50Pr0, Her2 negative. Initial ihc was Er90Pr30 adter surgery. Im concerned that the Er expression is,dropped which reduced affectiveness of endicrine therapy. Suggest the approaches to unsilence Er
Adding CDK4/6 inhibitors to endocrine therapy 2. Using different classes of endocrine therapy (switching between aromatase inhibitors, fulvestrant, or tamoxifen) 3. Considering clinical trials testing novel combinations
According to ESMO Guidelines:
- Epigenetic modifications can contribute to reduced ER expression
- Some clinical trials are investigating drugs called "epigenetic modifiers" that might help restore ER expression
- DNA methyltransferase inhibitors and histone deacetylase inhibitors are being studied for this purpose
Important recommendations:
- Discuss these findings with your oncologist to determine the best treatment strategy
- Consider genomic testing if not already done to identify potential targeted therapy options
- Ask about clinical trials investigating treatments for reduced ER expression
Remember: While ER expression has decreased, 50% is still considered positive and endocrine therapy can still be beneficial. Your oncologist can help determine the optimal approach based on your specific situation.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Breast Cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →